Which vascular tumor is associated with lymphedema and may present after radiation therapy to the breast?

Which vascular tumor is associated with lymphedema and may present after radiation therapy to the breast?

• A. Angiosarcoma
• B. Kaposi's sarcoma
• C. Hemangioma
• D. Lymphangioma

Answer: (A)

This question hinges on recognizing a malignant vascular tumor that arises in chronic lymphedema, particularly after breast cancer treatment with radiation. Angiosarcoma is the classic lesion that fits this scenario. When lymphedema develops after breast surgery or after radiotherapy, the chronically swollen, lymph-stagnant tissue becomes susceptible to malignant transformation of the endothelial cells, leading to an angiosarcoma. Clinically, it often presents as rapidly enlarging, bruise-like or violaceous skin nodules on the irradiated breast or nearby skin. Histology shows atypical, infiltrating endothelial-lined channels, and immunostains like CD31 and ERG support a vascular origin. This is why angiosarcoma is the best fit for a vascular tumor associated with lymphedema and post-radiation breast changes. Kaposi's sarcoma is driven by HHV-8 infection and is primarily linked to immunosuppression or certain geographic contexts, not specifically to lymphedema after radiation. Hemangioma and lymphangioma are benign lesions and do not share the same association with chronic lymphedema following breast radiotherapy.

This question hinges on recognizing a malignant vascular tumor that arises in chronic lymphedema, particularly after breast cancer treatment with radiation. Angiosarcoma is the classic lesion that fits this scenario. When lymphedema develops after breast surgery or after radiotherapy, the chronically swollen, lymph-stagnant tissue becomes susceptible to malignant transformation of the endothelial cells, leading to an angiosarcoma. Clinically, it often presents as rapidly enlarging, bruise-like or violaceous skin nodules on the irradiated breast or nearby skin. Histology shows atypical, infiltrating endothelial-lined channels, and immunostains like CD31 and ERG support a vascular origin. This is why angiosarcoma is the best fit for a vascular tumor associated with lymphedema and post-radiation breast changes.

Kaposi's sarcoma is driven by HHV-8 infection and is primarily linked to immunosuppression or certain geographic contexts, not specifically to lymphedema after radiation. Hemangioma and lymphangioma are benign lesions and do not share the same association with chronic lymphedema following breast radiotherapy.